-
Austrian Company Launches Another Parkinson’s Vaccine Trial
December 16, 2014
… AFFiRiS chief medical officer, presented safety findings from the first clinical trial of a vaccine against … study tests a different drug (PD03A). “The vaccine comes from a designated pool of promising vaccine candidates based …
-
(SUPPLEMENT) Discovery of Translational Biomarkers for Endolysosomal Pathway Pathology Using Lipidomics and Metabolomics
… This grant builds upon the research from a prior grant: Discovery of Translational … with models of endolysosomal pathology in PD and samples from people with PD and healthy volunteers, we will use …
-
Alterations in DNA Repair Mechanisms in Parkinson’s Disease Neurons and their Correlation with Clinical Variables
… biology. Hypothesis: We hypothesize that neurons obtained from reprogrammed skin cells of people with PD will display … cell biology technologies to transform skin cells obtained from people with PD into neurons. We will then treat these …
-
Use of the Dual-action Neuroprotective Compound KLS-13019 to Treat Motor Impairment in a Preclinical Model of Parkinson’s Disease
… drug candidate, KLS-13019, both protects mitochondria from chemical stress and displays anti-inflammatory … is currently being tested for safety with support from the National Institutes of Health for another …
-
Foundation Partners with the National Institutes of Health on Critical Biomarker Search
October 7, 2012
… the biomarker search: PPMI data is being used by scientists from around the world to validate potential biomarkers … To date, more than 34,000 data downloads have been made from PPMI by scientists in the field. Still, the …
-
Foundation Partners with the National Institutes of Health on Critical Biomarker Search
November 7, 2012
… the biomarker search: PPMI data is being used by scientists from around the world to validate potential biomarkers … To date, more than 34,000 data downloads have been made from PPMI by scientists in the field. Still, the …